Fixed Drug Eruption: Most Common Causative Medications
The most frequently implicated drugs in fixed drug eruption (FDE) are cotrimoxazole (trimethoprim-sulfamethoxazole), NSAIDs (particularly ibuprofen and naproxen), and antibiotics (especially tetracyclines and fluoroquinolones).
Primary Offending Agents
Sulfonamide Antibiotics (Most Common Overall)
- Cotrimoxazole (TMP-SMX) is consistently the leading cause across multiple studies, accounting for 36-75% of FDE cases 1, 2, 3, 4
- Sulfadiazine also implicated in 12.4% of cases 3
- Important caveat: Delayed skin testing (intradermal and patch testing) has poor sensitivity for FDE caused by sulfonamides 5
NSAIDs (Increasingly Recognized, High Mortality Risk)
- Nonsteroidal anti-inflammatory drugs cause 48.7% of generalized bullous FDE (GBFDE), the severe variant 6
- Specific agents include:
- Critical warning: NSAIDs are available over-the-counter in many countries, making them a significant public health risk for GBFDE, which carries 15.2% mortality 6
Antibiotics (Second Most Common Class)
- Fluoroquinolones (particularly norfloxacin) were the most common cause in one recent study (56% of cases) 9
- Tetracyclines cause 15.9% of FDE, with a distinctive pattern affecting only the glans penis 3
- Other antibiotics: metronidazole, tinidazole, amoxicillin, ampicillin, erythromycin, clindamycin 4
Analgesics and Antipyretics
Less Common but Documented Agents
- Anticonvulsants: phenobarbitone 4
- Antiparasitics: pyrantel pamoate, albendazole 4
- Immunomodulators: levamizole (associated with constitutional symptoms) 3
- Antifungals: griseofulvin 4
- Others: allopurinol, orphenadrine, chlormezanone 4
Drug-Specific Clinical Patterns
Understanding these patterns helps identify the causative agent when drug history is unclear:
- Cotrimoxazole: Predominantly affects male genitalia, lips (91%), trunk and limbs (89%), minimal mucosal involvement 2, 3
- Tetracycline: Exclusively affects glans penis, sparing other sites 3
- Naproxen: Predominantly affects lips and face 2
- Dipyrone: Mainly causes FDE on trunk and extremities, sparing lips, genitalia, and mucosae 2, 3
- Fluoroquinolones: Associated with both cutaneous (48%) and mucosal lesions (14%), most common cause of bullous and generalized bullous FDE 9
Critical Clinical Considerations
Latency period: Median onset is 24 hours (range 12-72 hours) for GBFDE 6, but first episodes average 6.5 days while subsequent episodes occur within 4.3 hours 9
Mortality risk: GBFDE has 15.2% mortality, significantly associated with older age 6. The widespread availability of over-the-counter NSAIDs poses particular risk.
Diagnostic confirmation: Oral provocation testing remains the only reliable method to confirm the causative drug and avoid false incrimination 1. However, skin testing has limited utility, particularly for delayed reactions 5.
Common pitfall: Patients may not report over-the-counter medication use (especially NSAIDs and ibuprofen), making diagnosis challenging 7, 8. Always specifically ask about all OTC medications, including those taken "as needed."